Author: CDPC

  • Canadian Drug Policy Coalition/ Doalition canadienne des politiques sur les drogues

    Ceasefire Now

    The Canadian Drug Policy Coalition (CDPC) is working towards a future in which drug policies and legislation, as well as related institutional practices, are based in evidence, human rights, equity, and public health principles. We recognize that current drug policy is rooted in colonial systems and structures and are working to centre decolonialism, anti-racism, and abolitionist values and practices in our efforts.   

    At this moment, it is impossible for CDPC, as an organization that works to uphold human rights, combat racism, and defend autonomy, to remain silent. We support and echo: 

    1. demands for an immediate ceasefire to stop genocide in Palestine, unconditional humanitarian access to Gaza, the protection of civilians and humanitarian personnel, and immediate end to the destruction of housing and life-sustaining infrastructure in Gaza; 
    2. demands to release all hostages and political prisoners;
    3. condemnation of Canada’s failure to support key UN resolutions to end catastrophic violence and illegal settlements; 
    4. calls to condemn and take action to end the recent spike in anti-Palestinian, anti-Arab, Islamophobic and antisemitic sentiment and violence across the country and the world; 
    5. calls to defend freedom of expression, and demonstrations of solidarity without harassment or retribution; 
    6. academics in their work to interrogate Canada’s foreign policy as informed and shaped by its own history of settler colonialism

      CDPC knows there is more to be said regarding the humanitarian crisis and mass displacement of the Palestinian people from Gaza and the West Bank unfolding before us, and more work to do in expressing solidarity. This is a statement on behalf of CDPC as one organization, not a network of organizations. We are committed to working with our network partners to articulate the interconnectedness of these struggles for freedom and human rights. We are committed to continued learning and engagement, and to advancing our mandate in ways that centre human rights, evidence and people who use drugs through processes of shared learning and co-creation. 

      We aim to approach our learning and action with humility and, as with all our work, we seek to centre lived experience, evidence, and human rights and to engage through collaboration and co-development with network partners. CDPC is committed to ongoing learning and action as best we can. We know that this takes commitment and that our grounding and ability to name intersecting oppressions in solidarity with broader struggles will grow and expand over time. We also honour our commitment to developing our work in coalition with people who use drugs and the network of partners we collaborate with, and to build shared political consciousness both within our drug policy work and in how we seek to show solidarity. Below is a list of some of the sources we have been reflecting on in our ongoing learning. 

      Annex:  

      Statements (in alphabetical order):  

      Artists & Academics in Canada (4000+ signatures)

      Centre for Gender Advocacy

      Feministes racisées statement (FR)

      Hamilton’s open Letter in support of Sarah Jama  

      Hind Khoudary, journalist in Gaza, explaining the impact of the blockade of medication, treatment and menstrual products   

      Ireland’s Dun Laoghaire constituency’s TD (MP) statement

      Lawyers and law students defending freedom of pro-Palestinian expression

      Professors, Staff, Librarians of McGill University

      Backlash and response to Professors, Staff, Librarians of McGill University

      People’s Potato (Concordia university)

      The Red Nation – Indigenous solidarity with Palestine

      Spain’s minister of social rights 

      SPHR Concordia  

      Zahraa Al-Akhrass’, the only Palestinian journalist at Global News, after being fired   

      Journalists on the ground (in alphabetical order):  

      Plestia Alaqad  

      Motaz Azaiza  

      Bisan  

      Yara Eid, based in London, one of the only surviving journalists of Ain Media  

      Ahmed Hijazi  

      Saleh Al Jafarawi (graphic content)  

      Hind Khoudary  

      Sources :

      https://www.cjpme.org/2022_05_31_canada_exports_arms

      https://globalnews.ca/news/10056886/canadian-special-forces-deployed-israel/

      https://byblacks.com/news/item/3611-black-community-rallies-around-ousted-mpp-sarah-jama-nobody-should-be-censored-for-condemning-what-the-un-has-documented-for-decades

      https://www.instagram.com/p/Cy_YCzYLGpc/

      https://www.ohchr.org/sites/default/files/Documents/Issues/SForum/SForum2015/MahmoudDaher.pdf

      https://www.newarab.com/news/displaced-palestinians-gaza-are-hungry-and-terrified

      https://www.unfpa.org/sites/default/files/resource-pdf/UNFPA-Situation-Report-2.pdf

      https://ir.lib.uwo.ca/cgi/viewcontent.cgi?article=1000&context=undergradawards_2021

        

    1. When law and policy is unjust, communities have no choice but to act.

      When law and policy is unjust, communities have no choice but to act.

      The Vancouver Police Department (VPD) arrest of Drug User Liberation Front (DULF) founders on October 25th, 2023 is an act of political and moral cowardice.  

      In the context of unrelenting loss driven by the unregulated drug market, DULF has taken courageous and ethical action to supply safety-tested substances to people who use drugs at great personal risk of arrest under Canada’s controlled substances laws.  

      DULF’s work saves lives. Through their small, community-led model of safe supply, they have demonstrated how access to safety-tested drugs of known potency and contents can reduce overdose, keep people alive, reduce hospitalizations and stabilize lives. DULF’s work has support from leading researchers, physicians and health care providers, public health officials, and community groups. 

      DULF has been transparent and communicative about their actions. They have made every effort to proceed legally, including by applying for an exemption from Health Canada which was denied last year. In the midst of the ongoing unregulated drug crisis, DULF made the ethical choice to proceed without formal approval.  

      The VPD chose to enforce these unjust laws after more than a year of DULF’s compassion club operating in plain sight. There is no conceivable possibility that the VPD, the City of Vancouver, the Province of BC or any other public or private actor with any familiarity with the drug policy landscape in Canada has been unaware of DULF’s actions since their first action. Police have discretion as to when, where and how to enforce the law — they chose the path of harm, and they did not have to.  

      When law and policy is unjust, communities have no choice but to act. The VPD themselves agree that their actions could “absolutely” result in drug users who rely on the compassion club’s services consuming more dangerous substances. Premier David Eby said earlier this week that while DULF is doing life-saving work, the government cannot tolerate illegal activity. The BC government and the VPD are using the law as a shield to justify what even the VPD admit is a dangerous and harmful act.  

      People who use drugs have long known they must take care of each other in the face of government violence and neglect. Sterile needle distribution was once illegal; Insite, Canada’s first legal safe injection site, overcame multiple legal challenges to exist. History has demonstrated that drug law and policy change lag far behind need, and that governments will eventually adopt the lifesaving responses that communities of drug users initiate. We believe this pattern will be replicated, and that history will once again vindicate DULF’s actions.  

      Until then, we unequivocally assert our support for DULF founders and their life-saving work. Inspired by them, we will continue to advocate for urgent and vital reforms to drug law and policy with every tool we have.

    2. Canadian Drug Policy Coalition/ Doalition canadienne des politiques sur les drogues

      Unions Can Take a Stand on Drug Policy

      Bad drug policy hurts workers. You’d be hard-pressed to find somebody in this country whose community hasn’t been affected by the drug poisoning crisis.

      That’s why it’s so important when labour unions take a stand on drug policy.

      There’s momentum building in the labour movement to protect workers and their communities from the unregulated drug supply that causes so much harm. In the last year, we’ve seen unions pass unanimous and near-unanimous resolutions at conventions declaring their support for safe supply, decrying involuntary treatment and demanding regulation for the treatment industry. 

      We would like to thank these unions for their leadership, passing resolutions on drug policy:

      If you’re a union member and your union isn’t on this list, you can organize your fellow workers. Reach out to [email protected] for more information.

      For more than a hundred years, the labour movement has been a driving force for social and economic change in this country. Whether it be childcare, healthcare, workplace safety or environmental protection, with the strength of hundreds of thousands of members, union power can propel massive shifts toward more equitable, safer communities. Labour and organized workers can play a key role in work to end the drug war and reinvest in our communities.

      Together we say: No More Drug War on the Shop Floor!

    3. World Aids Day 2013: If our goal is zero, drug policy reform is crucial

      World Aids Day 2013: If our goal is zero, drug policy reform is crucial

      Zero New HIV Infections. Zero Discrimination and Zero AIDS-related deaths. That is the goal set by UNAIDS over the next two years. But when it comes to stopping HIV transmission associated injection drug use, we have a long way to go.

      “An effective AIDS response among people who inject drugs is undermined by punitive policy frameworks and law enforcement practices” (UNAIDS 2013)

      The 2013 UNAIDS Global report notes that HIV prevalence among people who inject drugs ranged from 5% in Eastern Europe to 28% in Asia.  Rates of HIV among drug injectors in Canadian cities range from approximately 5% to more than 30%. According to Canada’s own Public Health Agency, more than 50% of new HIV infections among Aboriginal people in Canada were caused by intravenous drug use. Rates of HIV and hepatitis C among people incarcerated behind the walls of Canada’s prisons are 10 to 30 times outside those same walls. Although Corrections Canada claims that injection drug use is strictly prohibited within its facilities, no prison system in the world is able to keep drug use out.  But only two of 32 reporting countries surveyed by UNAIDS provided adequate access to sterile syringes for persons who injects drugs in prison.

      In 2012 the Global Commission on Drug Policy released a groundbreaking report titled “The War on Drugs and HIV/AIDS: How the Criminalization of Drugs Fuels THE Global Pandemic.” The report points to the inability of law enforcement to reduce global drug supply and raises the alarm about the role that repressive drug control policies play in driving the HIV epidemic in many regions of the world. The report also details how policies that prohibit needle distribution result in increased syringe sharing.  In fact the Global Commission confirms what others have been saying: the fear of arrest drives people underground and away from needed services. Together these repressive policies help to escalate HIV infections. The Commission urges countries to make available proven drug treatment and harm reduction services, to reduce HIV infection and protect community health and safety.

      It’s clear that ending prohibition and scaling up harm reduction is an integral part of solving the complex global HIV problem. By drawing on the evidence of what works, British Columbia has made significant strides at reducing infection rates, but our federal government willingly refuses to acknowledge the role that harm reduction plays in protecting everyone’s health.

      On September 30, 2013, the second anniversary of the Supreme Court of Canada decision that instructed the Canadian government to issue a permit for the supervised injection site, Insite in Vancouver, we worked with the Canadian HIV/AIDS Legal Network and PIVOT Legal Society to register our concerns to Health Minister Ambrose about attempts by the federal government to block the implementation of life-saving health services for people with addictions, in the face of extensive scientific evidence of their benefits in protecting public health and public safety. Our letter  to Ambrose, which garnered the support of more than 50 organizations in Canada, challenged her government to get going on life-saving harm reduction services. We are still waiting for a response.

      Along with our commitment to World Aids Day, we will also continue to mark September 30 (9-30), the anniversary of the Supreme Court decision supporting Insite. We invite you to join us and help ensure that supervised consumption services become a part of the continuum of care for people who use drugs in Canada. And finally, please consider contributing to help our small but mighty team continue to work for evidence based and human rights focused drug policy reform in Canada.

    4. Voices of the Drug War: Mexico and Canada

      Voices of the Drug War: Mexico and Canada

      In Mexico the drug war has had a devastating impact on communities, families, the social fabric and the economy. Deepen your understanding of the complex roots of this tragedy and hear ideas for new and better ways forward.

      Join the Canadian Drug Policy Coalition, Global Exchange and the Movement for Peace with Justice and Dignity for an evening with Javier Sicilia and Teresa Carmona.  Both of these outstanding Mexicans have lost children in the drug-war-driven violence of recent years. Both have chosen to forge their tragedies into opportunities to become agents of the changes so urgently needed in Mexico as well as in North America.
      Mr. Sicilia and Ms Carmona will share their experiences as both victims of the drug war and founders of an important peace movement. They will lead a discussion on why they are committing the moral weight of Mexico’s Movement for Peace with Justice and Dignity to the call for drug policy reform throughout our hemisphere.

      In Canada the drug war has had devastating impacts on individuals, families and communities across the country. Canada’s current drug laws support a lucrative underground and violent drug trade, fuel the spread of HIV and Hepatitis C, disproportionally target marginalized populations, and ensure the availability of illegal drugs to young people in our communities. Bud Osborn poet and Downtown Eastside activist will read and talk about his own journey through the drug war in North America.

      Donald MacPherson, Director, Canadian Drug Policy Coalition will moderate the discussion and highlight the opportunities coming towards us to accelerate the movement for ending the war on drugs.

      You are invited to attend – Voices of the Drug War: Mexico and Canada

      Register here: drugpolicy.ca/javier-sicilia/

      Monday, October 28, 7-9 PM
      World Arts Room
      SFU Woodward’s
      149 West Hastings Street
      Vancouver, BC

      For more info: [email protected]


      donate1The Canadian Drug Policy Coalition relies on donations from people like you to operate. Our small team ensures even the smallest contributions go a long way to make your voice heard. Please donate today.

       

    5. The Evidence Enigma: Correctional Boot Camps and Other Failures in Evidence-Based Policymaking

      The Evidence Enigma: Correctional Boot Camps and Other Failures in Evidence-Based Policymaking

      Book review:

      The Evidence Enigma: Correctional Boot Camps and Other Failures in Evidence-Based Policymaking, Tiffany Bergin, (Ashgate, 2013), 213 pages.

      Why do policy makers adopt policies for which there is no evidence that they will work or for which the evidence is clear that they will not work? Why do they continue to defend policies which have demonstrably failed or for which the unintended consequences are so costly as to undermine their rationale? Why do policy makers ignore evidence that policies are failing thereby squandering resources that could be diverted to policies with a better track record? The Evidence Enigma does not answer all of theses questions, but it does shed some light on the complexity of policy making in one highly contested policy domain.

      Bergin begins with a question: What explains the rapid diffusion of boot camps – correctional facilities inspired by military drills, physical exertion and rigid discipline – to almost every U.S. state during the 1980s and 1990s when it was clear that these facilities were not reducing either recidivism rates, prison overcrowding or justice system costs? Their failure to achieve any of these objectives did not reduce their appeal to policy makers – indeed their popularity grew with evidence of their failure to deliver on their promises. The same questions can be posed for Drug Abuse Resistance Education (DARE), which survives in many jurisdictions despite numerous well-designed meta-analyses and evaluations demonstrating little to no deterrent effect on participants. The granddaddy of all failed policies to which policy makers are still committed, of course, is the war on drugs. The example of boot camps, however, is particularly interesting because so much was known about them so early in their diffusion across the United States.

      Bergin employs a multi-method approach to unravel her problem, involving extensive quantitative, qualitative and event history analysis of the diffusion and then contraction of the boot camp model, the racial composition of jurisdictions in which boot camps were located, the economic conditions for which boot camps were supposed to be a partial remedy, the geographic proximity of one boot camp jurisdiction to another, the prevalence of military veterans among policy makers in a given jurisdiction, the pervasiveness of media articles about boot camps, the influence of federal funding programs, the percentage of Evangelical Christians in a given jurisdiction, the north-south geographic location of boot-camp jurisdictions, the nature of local electoral competition and numerous other variables.

      She finds that boot camps were more likely to be adopted in jurisdictions with higher adult incarceration rates and conservative populations; more popular in jurisdictions with higher percentages of African Americans and Evangelical Christians and higher levels of income inequality. In fact, these three variables correlate reliably with early adoption of boot camp regimes. Furthermore, state governors who were military veterans – and jurisdictions with a high percentage of military veterans in their populations – were less likely to abolish boot camps once the contraction set in.

      Of the contending theoretical streams, Bergin finds that Windlesham’s populist theory – a conservative political climate in a racially charged environment – was the strongest predictor of the adoption of boot camps. By contrast, Kingdon’s theory that boot camps found their way onto legislative agenda in response to “problems” – i.e., high rates of crime, incarceration and levels of prison overcrowding – found little support in the analysis. Boot camps, in other words, were not so much a solution to a problem but a predilection arising out of the particular ideological needs of specific populations and their political leadership.

      Bergin’s analysis concludes that the diffusion of boot camps is easier to explain than their contraction. Jurisdictions with higher levels of military veterans, higher levels of Black and Hispanic populations and greater numbers of Evangelical Christians proved more resistant to the evidence that boot camps were not delivering savings, lower rates of re-offending or reduced rates of prison overcrowding.

      So what light does this study – of one policy model in the United States – tell us about the general problem of policy makers’ adherence to failed policies, or to policies for which there is no support in evidence or for which the evidence contradicts the policy preference? No single theory of policy diffusion seems adequate: all explain some aspect but leave other issues unaddressed. Missing from Bergin’s account is a discussion of power – specifically the power to frame a particular problem area as responsive to a preferred policy response. What we have, in the boot camp example, are indicators of kinds of power without an articulate account of how power frames and circumscribes the limits of the possible – making some options live and rendering others out of order.

      Policy makers do not simply do what they want, particularly in a realm like criminal justice, which is costly and involves deprivation of liberty. They must fashion responses according to the menu of available and acceptable options and within the requirements of electoral survival – which involves a shrewd estimation of what their constituents will endorse or at least tolerate. When populations are largely passive in their preferences, of course, policy makers can exercise discretion – but when policy makers are constrained by electoral competition, the need to be seen to be doing something can overwhelm even the most honourable political instincts. The need to be seen to be doing something – which is distinct from the reality of actually doing something – looms large in domains like criminal justice where policy makers know, or rapidly learn, that they can do little of long-term substance in the short mandates available to them. This is how we come to see – particularly in criminal justice – the triumph of symbol over substance and the willingness to subordinate principle to electoral opportunity.

      Bergin’s study of boot camps offers valuable insights into the diffusion and contraction of a discredited policy – but the book provokes as many questions as it answers. And that is often the mark of a good book.

      – Craig Jones, PhD

      Craig Jones is the former Executive Director of The John Howard Society of Canada.

    6. Canada’s New Marijuana Medical Access Program

      Canada’s New Marijuana Medical Access Program

      On June 10, 2013 the Minister of Health released the new regulations that will govern access to cannabis for medical purposes in Canada. The regulations are the result of consultations over the past two years and introduce significant changes to the program. The regulations eliminate previous requirements that patients submit an application to Health Canada requesting authorization to possess cannabis. Instead they must seek a document from their physicians that they would then present to a licensed producer. Though this move could potentially streamline access to cannabis for medical purposes, the Canadian Medical Association has released a report that suggests that many physicians believe they do not know enough about the benefits and risks of cannabis to “prescribe” it to their patients for medical purposes. The irony of this situation is that the prohibition of cannabis has limited the amount of research into its medical benefits (though research is increasing).

      In addition, the new rules eliminate personal and designated production by individuals in their homes by March 31, 2014. This means that current options to access cannabis for medical purposes will be replaced by regulated and commercial Licensed Producers and medical cannabis dispensaries remain excluded from the supply chain by these new regulations. Many patients produce their own cannabis in order to access strains that they have found to be helpful. Maintaining one’s own garden is also cost-effective. Even the government’s own regulatory impact statement notes that the cost of medical cannabis will go up with the new rules. These cost increases could potentially act as further barriers to accessing cannabis for medical purposes.

      The exclusion of medical cannabis dispensaries from the supply chain is counterintuitive. The personnel working in these dispensaries are experts on using cannabis to treat a variety of medical conditions. Dispensaries also offer a range of patient-centred services and supports that help challenge the isolation many patients experience. And Canadian medical cannabis dispensaries have developed a rigorous accreditation program to ensure consistency in both the quality of their services and the products dispensed at these sites. Without dispensaries, patients will have to submit their doctor’s authorization to a licensed commercial producer and then receive their medication by courier, without the supports accorded by face-to-face consultations.

      The odd thing about the new rules is that they introduce a fully commercialized route of access to cannabis for medical purposes while keeping the overall prohibition of this drug fully in place. Indeed some of the provisions for producers of cannabis for medical purposes may serve as a model for production of cannabis for a legal, regulated market. At the same time, the requirements for licensed producers are quite strict and could make it very difficult for small growers to transition to this new regime. It is also unclear how many licensed producers will be approved by Health Canada. This later point is key for patients who want to able to access a range of strains of cannabis.

      All in all, these new rules will likely result in new barriers to accessing cannabis for medical purposes and will end up costing patients more money over the long-term.

      – Connie Carter & Lynne Belle-Isle

    7. Sometimes Violations of International Law Are Cause for Celebration

      Sometimes Violations of International Law Are Cause for Celebration

      The United States is again in violation of international law. That is a strong statement and one that reminds us of the invasion of Iraq, Guantanamo bay, water-boarding, rendition, and the strong international legal arguments made about these situations.

      But in this case the violation will be hailed by many as a positive step.

      On 6 November various ballot initiatives were voted on in the US, from abolishing the death penalty to allowing assisted suicide, to legalising gay marriage. Three had the clearest potential to render the US in breach of international law if they succeeded. With the votes in Colorado and Washington which established a legally regulated framework for non-medical production and sale of marijuana, that breach has now occurred.

      The laws in question are the 1961 UN Single Convention on Narcotic Drugs and the 1988 UN drug trafficking conventions (which has a longer, duller title). Alongside one other treaty (which deals with synthetics) these form the bedrock legal foundation of the global drug control regime. Most countries follow them very closely, including the US.

      Some states have been pushing at the boundaries of these treaties for some time, however, on particular points of contention that have developed in the decades since the treaties were negotiated. Times have changed since 1961. Grey areas have been exploited, arcane scheduling systems utilised, and interpretations adopted that allow more room for manoeuvre.

      But what sets these ballot initiatives apart is that there is no grey area to exploit, and it would take some legal gymnastics to interpret your way past that. This is straight up legalisation of recreational use, production, and sale, which is not permitted. It’s what the system was set up in large part to prohibit, with marijuana receiving particular attention alongside coca and opium. While most substances are listed in annexed schedules, these three are written into the very terms of the treaties (‘cannabis’ is the term used).

      The US (alongside over 180 other states) is required, under a very robust and politically supported regime, to ‘limit exclusively to medical and scientific purposes the production, manufacture, export, import, distribution of, trade in, use and possession of drugs’.

      There is more, of course, and there are various provisos and caveats on certain provisions, but this is a ‘general obligation’ of the regime around which all else revolves. In other words, the US is not just in breach of some marginal aspect of the system, now, but a fundamental requirement of it that goes to the heart of prohibition.

      Millions of US citizens are now permitted to buy and sell marijuana for recreational purposes (regulations pending). These laws apply to a population far exceeding that of Sweden (where I am currently sitting) and way over twice the size of Ireland (where I’m from). This would be supported by neither government, which have signed contracts with the US in the form of these international agreements to the effect that none of them would allow it. The fact that this has happened at state and not federal level does not rectify the legal dilemma the US government now faces.

      Many in the US and worldwide are celebrating the results in Colorado and Washington as the beginning of the end of the war on drugs – and appropriately through a democratic process. People have voted for the US to breach international law. That very few would have cared or knew about this is not relevant. This is the fact of it.

      There are now four possible scenarios. The US Federal Government can fight it out, stepping all over state sovereignty. The US can withdraw from the treaties in question. The treaties themselves can be changed by international processes. Or the US can carry on in breach and turn a blind eye. I think the fourth is the most likely. Ironically, this leads inexorably to arguments for broader reform, but this is something the US overnment has ardently opposed, even signing a recent declaration with the Russians to that effect.

      So the implications for international law and the place of the UN drugs conventions within it must be considered.

      We would not celebrate an ongoing breach by the US of the Convention on the Elimination of Racial Discrimination or the International Covenant on Civil and Political Rights, to which it is also bound. Nor would we tolerate (though they happen regularly) violations of the Geneva Conventions, the Torture Convention, the Nuclear Non-Proliferation Treaty or environmental protocols. Indeed, there is a hierarchy in international law that is exposed by the Colorado and Washington votes.

      But it is one within which the drug control regime has an unnaturally elevated position due to the widespread political consensus around prohibition, and fears that have been intentionally fuelled over the years. Drugs, in the UN conventions, are seen as a threat to mankind, and an ‘evil’ to be fought. Over time, respect for the UN drugs conventions has been equated with respect for the rule of law itself. ‘The three United Nations drug control conventions…set the international rule of law that all States have agreed to respect and implement’ said the President of the UN’s International Narcotics Control Board (INCB) in a recent speech. (The INCB is the body that monitors States’ implementation of the drugs conventions). He has confused the rule of law with specific laws.

      There are some things that are wrong in themselves (malum in se) and things that are wrong because they are prohibited (malum prohibitum). But when it comes to drug laws, fighting something that is prohibited has resulted in widespread acts that are wrong in themselves and that breach basic legal principles – the rule of law.

      The racially discriminatory nature of drug laws is common knowledge. Some governments rely on the international regime to justify executions of people convicted of drug offences (in violation of international law, in fact). Police violence, mass incarceration, denial of due process are routine in States’ pursuit of the general obligation the US now breaches.

      The international legal arguments about the Colorado and Washington results will certainly arise. They must, though it will likely be in the rather closed and stale environment of UN drugs diplomacy. When that happens it must emerge is that these ballots are a victory for the rule of law even as they bring the US into conflict with the drugs conventions. Fundamental legal principles of proportionality, fairness and justice, not to mention democracy, have won out over arbitrary and unreasonable controls on human behaviour.

      Ending the war on drugs, moreover, will be a victory for international human rights law. It will be a victory for international law itself – for environmental law, anti-corruption agreements, international security, for the achievement of international development agreements and improved health – all of which have been damaged by decades of prohibition. Colorado and Washington have taken us one step closer. For that we should all celebrate.

      – Damon Barrett

      Damon Barrett is Deputy Director of Harm Reduction International, co-founder of the International Centre on Human Rights and Drug Policy, and an Editor-in-Chief of the journal Human Rights and Drugs.  This blog post was first published on Damon’s Huffington Post blog and the Transform website.

    8. Training Drug Users and Bystanders to Treat Overdose Saves Lives

      Training Drug Users and Bystanders to Treat Overdose Saves Lives

      Drug overdose is a growing public health crisis that now kills more adults per year in the United States than motor vehicle accidents. In cars, seatbelts and airbags save lives. When it comes to opioid overdose a safe and non-abusable medicine called naloxone can restore breathing and avert death. Pragmatic doctors and health officials want anyone who uses opioids like heroin—and anyone likely to be around during an overdose—to have access to this life-saving drug, and know how to use it.

      In Massachusetts, researchers led by Dr. Alexander Walley at the Boston University Medical Center set out to discover the results of a state-supported overdose education and naloxone distribution program on deaths from overdose. We sat down with Dr. Walley to discuss the findings.

      What did your research find?

      This study demonstrates that overdose education and naloxone distribution is an effective public health intervention to address the growing overdose epidemic. We found that communities that received overdose education and naloxone reported significantly fewer deaths than communities that received no training. We also observed that the higher the cumulative rate of program implementation, the greater the reduction in death rates. In other words, the more people at risk or in contact with people at risk for overdose who were given naloxone, and trained to prevent, recognize and respond to an overdose, the lower the overdose death rates.

      Why are overdose education and naloxone delivery programs like these so important?

      Since the beginning of the Massachusetts overdose education and naloxone delivery programs, there have been more than 1,700 overdose rescues using naloxone. While we do not know how many of these people may have died if they had not received naloxone, it is likely that many of them would have. These rescues have inspired many us to maintain hope that all overdose deaths can be prevented.

      People who have recently stopped using opioids—whether because of jail time or treatment—are at increased risk of overdose, and we’ve heard inspiring stories of overdose reversals in these cases. While opioid addiction is a treatable disease, it is a chronic disease where relapse is unfortunately part of the natural history. Preventing overdose allows people to continue their progress towards recovery, and may enable them to seek out other lifesaving services.

      What barriers stand in the way of implementing programs like this in other parts of the United States?

      I’ll start first by listing features of the program in Massachusetts that contributed to its success and would support broader implementation: one is the use of a nasal delivery device for naloxone, allowing naloxone to be administered through the nose, instead of by injection. The other is a standing order issued by the health department that permits non-medical personnel to deliver overdose education and distribute naloxone. Without this order, a doctor would need to be present each time naloxone is given out. To date, there are still large parts of the country with no access to a lifesaving naloxone distribution program; though this program locator tool can help you find out if there is one near you.

      The two main barriers to the expansion of these initiatives are that insurance companies do not cover the nasal delivery device that allows naloxone to be administered through the nose, and prescribers (doctors, nurse practitioners and physicians’ assistants) are not yet adequately educated on prescribing naloxone. We’ve created a website, prescribetoprevent.org, to help facilitate naloxone prescribing.

      What message would you send to officials in countries like Russia and China where the death toll from drug overdoses continues to climb?

      Preventing needless deaths from opioid overdose is a bridge issue – it’s a cause that people from different perspectives on treatment and harm reduction can agree and work together on. It can be a starting point from which we can work together in addressing the harms associated with drug use.

      What happens now?

      We keep implementing and evaluating this program and ones like it. In Massachusetts, overdose education and naloxone have been delivered to heroin users, prescription opioid users, patients in emergency departments, and the people who are most likely to respond to an overdose including: people who are incarcerated, family members, social service providers, police officers, and firefighters. It is important to determine how these programs should be tailored to different populations to maximize their reach, effectiveness and sustainability. That’s what we’re working on now.

      This blog post was originally published on the Open Society Foundations website.